Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increased Corticosteroid Dosing in Neurocysticercosis
NCT00290823Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2006
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in neurocysticercosis (NCC), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2006; status: completed.
02
Drugs
dexamethasone
03
Conditions
neurocysticercosis (NCC)
Beyond the preview
Go deeper on NCT00290823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290823.